The British government has set a goal of vaccinating 2 million people within two weeks of the start of distribution.
The plan includes doses of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines. According to The Telegraph.
The Oxford vaccine is expected to be approved by the UK Medicines and Healthcare Regulatory Agency within the next few days.
The first trials of the Oxford vaccine found that it was less effective than the already approved Pfizer and Modern vaccines, which have scored 95% and 94.5% efficacy so far.
AstraZeneca CEO Pascal Suriot has raised hopes for the vaccine, promising to publish a paper describing how the two-dose vaccine works.
“We believe we have found the winning formula and how to get an efficacy that, after two doses, will be present with everyone else,” Soryu In the Sunday Times.
However, the Ministry of Health said that regulators should be given sufficient time to conduct a review of the results of the Oxford vaccine.
A spokeswoman for the Ministry of Health said: “We must now give the Ministry of Health, Safety and Human Medicine time to do its important work and we must wait for her advice.” To Reuters.
The number of hospital admissions has increased across the country, partly due to a variable that is spreading 70% faster than previous variants of the Coronavirus.
In a leaked note, NHS Medical Director Steve Powis has instructed hospitals to be on high alert regarding the new variant and the South African strain.